Sanofi-Aventis U.S. LLC v. Aurobindo Pharma USA, Inc.

Application Number	Patent Number	External Links
-	US6794410	Espacenet Google Patents
-	US9186346	Espacenet Google Patents

COMPLAINT - filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2053340.) - filed by Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Genzyme Corporation. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(rwc) (Entered: 12/22/2016)

2016-12-22

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) (Entered: 12/22/2016)

2016-12-22

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/15/16. Date of Expiration of Patent: SEE ATTACHED.Thirty Month Stay Deadline: 5/19/2019. (rwc) (Entered: 12/22/2016)

2016-12-22

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,794,410 C1; US 9,186,346 B2. (rwc) (Entered: 12/22/2016)

2016-12-22

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Aventisub LLC, Genzyme Corporation, Sanofi-Aventis U.S. LLC filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 12/22/2016)

2016-12-22

1

View

Summons Issued

2016-12-22

1

No Actions

SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Genzyme Corporation. Aurobindo Pharma USA, Inc. served on 12/22/2016, answer due 1/12/2017. (Bove, Jeffrey) (Entered: 12/23/2016)

2016-12-23

1

View

SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Genzyme Corporation. Aurobindo Pharma Ltd. served on 12/22/2016, answer due 1/12/2017. (Bove, Jeffrey) (Entered: 12/23/2016)

2016-12-23

1

View

DECLARATION of Mailing (as to service on Aurobindo Pharma Ltd.) by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Bove, Jeffrey) Modified on 1/4/2017 (mdb). (Entered: 12/23/2016)

2016-12-23

1

View

Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:16-cv-01298-GMS, 1:16-cv-01299-GMS, 1:16-cv-01300-GMS (rjb)

2016-12-28

1

No Actions

Case Assigned/Reassigned

2016-12-28

1

No Actions

STIPULATION TO EXTEND TIME to respond to complaint to February 13, 2017 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) (Entered: 01/03/2017)

2017-01-03

1

View

SO ORDERED - re 9 STIPULATION TO EXTEND TIME to respond to complaint to February 13, 2017 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd., Set/Reset Answer Deadlines: Aurobindo Pharma Ltd. answer due 2/13/2017; Aurobindo Pharma USA, Inc. answer due 2/13/2017. Ordered by Judge Gregory M. Sleet on 1/4/2017. (mdb)

2017-01-04

1

No Actions

~Util - Set/Reset Answer Deadline AND SO ORDERED

2017-01-04

1

No Actions

Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/15/16. Date of Expiration of Patent: SEE ATTACHED.Thirty Month Stay Deadline: 3/12/2020. (Bove, Jeffrey) (Entered: 01/20/2017)

2017-01-20

1

View

MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, Brandon J. Kennedy - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 02/09/2017)

2017-02-09

1

View

STIPULATION TO EXTEND TIME for Defendants Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd. to answer, move or otherwise respond to the Complaint for Patent Infringement to March 6, 2017 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) (Entered: 02/13/2017)

2017-02-13

1

View

SO ORDERED - re 11 MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. Ordered by Judge Gregory M. Sleet on 2/14/2017. (mdb)

2017-02-14

1

No Actions

SO ORDERED

2017-02-14

1

No Actions

SO ORDERED - re 12 STIPULATION TO EXTEND TIME for Defendants Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd. to answer, move or otherwise respond to the Complaint for Patent Infringement to March 6, 2017 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd., Set/Reset Answer Deadlines: Aurobindo Pharma Ltd. answer due 3/6/2017; Aurobindo Pharma USA, Inc. answer due 3/6/2017. Ordered by Judge Gregory M. Sleet on 2/15/2017. (mdb)

2017-02-15

1

No Actions

~Util - Set/Reset Answer Deadline AND SO ORDERED

2017-02-15

1

No Actions

Add Attorneys - PHV only

2017-02-16

1

No Actions

Pro Hac Vice Attorney Brandon J. Kennedy, Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, and Ann C. Palma for Aventisub LLC, Genzyme Corporation, Sanofi, and Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)

2017-02-16

1

No Actions

ANSWER to 1 Complaint,, COUNTERCLAIM against All Plaintiffs by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd..(Dorsney, Kenneth) (Entered: 03/06/2017)

2017-03-06

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) (Entered: 03/06/2017)

2017-03-06

1

View

ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 3/6/2017. (asw) (Entered: 03/06/2017)

2017-03-06

1

View

STIPULATION TO EXTEND TIME to File Joint Status Report and Proposed Scheduling Order to May 11, 2017 - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A)(Bove, Jeffrey) (Entered: 03/22/2017)

2017-03-22

1

View

SO ORDERED - re 16 STIPULATION TO EXTEND TIME to File Joint Status Report and Proposed Scheduling Order to May 11, 2017 filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. Ordered by Judge Gregory M. Sleet on 3/22/2017. (mdb)

2017-03-22

1

No Actions

SO ORDERED

2017-03-22

1

No Actions

ANSWER to 13 Answer to Complaint, Counterclaims by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Certificate of Service)(Bove, Jeffrey) Modified on 3/28/2017 (mdb). (Entered: 03/27/2017)

2017-03-27

1

View

STIPULATION of Dismissal by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Certificate of Service)(Bove, Jeffrey) (Entered: 04/20/2017)

2017-04-20

1

View

SO ORDERED - re 18 Stipulation of Dismissal Without Prejudice filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. Signed by Judge Gregory M. Sleet on 4/24/2017. Civil Case Terminated (mdb) (Entered: 04/24/2017)

2017-04-24

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Stipulation of dismissal)(mdb) (Entered: 04/26/2017)

2017-04-26

1

View

Overview

Parties

Defendant

Sanofi Follow

Represented By

Aurobindo Pharma Ltd. Follow

Represented By

Aurobindo Pharma USA, Inc. Follow

Represented By

Sanofi-Aventis U.S. LLC Follow

Represented By

Plaintiff

Aventisub LLC Follow

Represented By

Genzyme Corporation Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) (Entered: 12/22/2016)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/15/16. Date of Expiration of Patent: SEE ATTACHED.Thirty Month Stay Deadline: 5/19/2019. (rwc) (Entered: 12/22/2016)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,794,410 C1; US 9,186,346 B2. (rwc) (Entered: 12/22/2016)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Aventisub LLC, Genzyme Corporation, Sanofi-Aventis U.S. LLC filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 12/22/2016)

Summons Issued

SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Genzyme Corporation. Aurobindo Pharma USA, Inc. served on 12/22/2016, answer due 1/12/2017. (Bove, Jeffrey) (Entered: 12/23/2016)

SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, Genzyme Corporation. Aurobindo Pharma Ltd. served on 12/22/2016, answer due 1/12/2017. (Bove, Jeffrey) (Entered: 12/23/2016)

DECLARATION of Mailing (as to service on Aurobindo Pharma Ltd.) by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Bove, Jeffrey) Modified on 1/4/2017 (mdb). (Entered: 12/23/2016)

Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:16-cv-01298-GMS, 1:16-cv-01299-GMS, 1:16-cv-01300-GMS (rjb)

Case Assigned/Reassigned

STIPULATION TO EXTEND TIME to respond to complaint to February 13, 2017 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) (Entered: 01/03/2017)

~Util - Set/Reset Answer Deadline AND SO ORDERED

Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/15/16. Date of Expiration of Patent: SEE ATTACHED.Thirty Month Stay Deadline: 3/12/2020. (Bove, Jeffrey) (Entered: 01/20/2017)

MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, Brandon J. Kennedy - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Bove, Jeffrey) (Entered: 02/09/2017)

STIPULATION TO EXTEND TIME for Defendants Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd. to answer, move or otherwise respond to the Complaint for Patent Infringement to March 6, 2017 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) (Entered: 02/13/2017)

SO ORDERED - re 11 MOTION for Pro Hac Vice Appearance of Attorney Paul H. Berghoff, Alison J. Baldwin, Paula S. Fritsch, Ann C. Palma, Brandon J. Kennedy filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. Ordered by Judge Gregory M. Sleet on 2/14/2017. (mdb)

SO ORDERED

~Util - Set/Reset Answer Deadline AND SO ORDERED

Add Attorneys - PHV only

ANSWER to 1 Complaint,, COUNTERCLAIM against All Plaintiffs by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd..(Dorsney, Kenneth) (Entered: 03/06/2017)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) (Entered: 03/06/2017)

ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 3/6/2017. (asw) (Entered: 03/06/2017)

STIPULATION TO EXTEND TIME to File Joint Status Report and Proposed Scheduling Order to May 11, 2017 - filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Exhibit A)(Bove, Jeffrey) (Entered: 03/22/2017)

SO ORDERED - re 16 STIPULATION TO EXTEND TIME to File Joint Status Report and Proposed Scheduling Order to May 11, 2017 filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. Ordered by Judge Gregory M. Sleet on 3/22/2017. (mdb)

SO ORDERED

ANSWER to 13 Answer to Complaint, Counterclaims by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Certificate of Service)(Bove, Jeffrey) Modified on 3/28/2017 (mdb). (Entered: 03/27/2017)

STIPULATION of Dismissal by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. (Attachments: # 1 Certificate of Service)(Bove, Jeffrey) (Entered: 04/20/2017)

SO ORDERED - re 18 Stipulation of Dismissal Without Prejudice filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. Signed by Judge Gregory M. Sleet on 4/24/2017. ***Civil Case Terminated*** (mdb) (Entered: 04/24/2017)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Stipulation of dismissal)(mdb) (Entered: 04/26/2017)

Track Case Updates

Sanofi

Aurobindo Pharma Ltd.

Aurobindo Pharma USA, Inc.

Sanofi-Aventis U.S. LLC

Aventisub LLC

Genzyme Corporation

SO ORDERED - re 18 Stipulation of Dismissal Without Prejudice filed by Aventisub LLC, Genzyme Corporation, Sanofi, Sanofi-Aventis U.S. LLC. Signed by Judge Gregory M. Sleet on 4/24/2017. Civil Case Terminated (mdb) (Entered: 04/24/2017)